Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.


4-H Canada and Bayer Renew Five-Year Commitment to Invest in Youth through STEM
Updated analysis for larotrectinib confirms high response rate and durable responses over three years in children and adults with TRK fusion cancer
Bayer Fund shares over $100,000 in funding with students through its Opportunity Scholarship Program
European Society of Cardiology recommends (rivaroxaban) XARELTO® 2.5 mg plus acetylsalicylic acid for patients at high risk of heart attacks, strokes and death due to chronic coronary syndromes
Bayer completes sale of iconic Coppertone™ brand to Beiersdorf
Health Canada approves VITRAKVI® (larotrectinib), the first tumour agnostic cancer treatment for advanced solid tumours harbouring an NTRK gene fusion
Yellow Wood Partners to acquire iconic Dr. Scholl’s™ brand from Bayer
Beiersdorf to acquire iconic Coppertone™ brand from Bayer